The report paints a picture of the UK as a vibrant hub for bioscience for creating life-changing advances.
As well as showcasing the talent and impact of these 50 leaders, the report distils their insights across five themes - science, finance, collaboration, patient impact and infrastructure – providing an invaluable resource for entrepreneurs, researchers and anyone interested in the direction of the industry.
Highlights include:
- Increasing population diversity in genomic datasets opening up precision healthcare for a global market.
- The next generation of bioscience entrepreneurs challenging conventional corporate culture and bringing new, more flexible ways of working.
- Opportunities for nimble start-ups that can demonstrate efficient testing and translation of new ideas from bench to bedside.
- Under-explored and potentially huge emerging markets, such as health technologies focussed on women’s and children’s health.
- Growing focus on ‘real life’ medicine, measuring meaningful patient outcomes and shifting towards long-term health monitoring and management.
- The synergistic tipping point of computation and biology, merging in vivo and in silico research to rapidly accelerate the pace and scale of innovation.
Introducing this year’s report, Melanie Lee, CEO of LifeArc, says, “Everyone working in life sciences shares a great mission: to discover, develop and deliver valuable solutions that improve health and wellbeing for humanity. The 50 Movers and Shakers in BioBusiness 2019 are outstanding examples of leaders delivering on this mission. There is a breadth of innovative, scientific ideas which are igniting biosciences in Britain and each of these women should be celebrated for leading in this thriving sector.”
BioBeat founder Miranda Weston-Smith adds, “It’s a privilege to connect with these incredible leaders, discovering their work and hearing their thoughts on the direction of the industry. Their insights guide our thinking on the opportunities and challenges facing the UK life sciences sector, revealing how to harness the brightest and best ideas to make a difference for patients. These women are the ones to watch!”
The 50 Movers and Shakers report is released in advance of the BioBeat19 summit: Accelerating Cell and Gene Therapy, hosted in partnership with GSK and Stevenage Bioscience Catalyst at GSK Stevenage on Tuesday 19 November 2019.
This year’s summit brings together an international lineup of speakers and panellists drawn from the commercial, academic and public sectors to explore the UK’s advantage and opportunities in this fast-growing field.
The full 50 Movers & Shakers in BioBusiness 2019 report is available to download here>>>
[[{"fid":"282903","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":"50 Movers and Shakers in BioBusiness 2019_ Biobreat","field_file_image_title_text[und][0][value]":"50 Movers and Shakers in BioBusiness 2019_ Biobeat"},"link_text":false,"type":"media","field_deltas":{"1":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":"50 Movers and Shakers in BioBusiness 2019_ Biobreat","field_file_image_title_text[und][0][value]":"50 Movers and Shakers in BioBusiness 2019_ Biobeat"}},"attributes":{"alt":"50 Movers and Shakers in BioBusiness 2019_ Biobreat","title":"50 Movers and Shakers in BioBusiness 2019_ Biobeat","class":"media-element file-default","data-delta":"1"}}]]
About BioBeat’s 50 Movers and Shakers in BioBusiness report
The women highlighted in this year’s report have been nominated by the biobusiness community, together with Miranda’s research and insights. The selection was reviewed by a distinguished panel of business leaders, entrepreneurs and pioneering scientists working in the UK life sciences sector.
It has been produced with the support of:
- Appleyard Lees
- Entrepreneurship Centre Cambridge Judge Business School
- GSK
- Innovation Forum
- Naked Ideas, branding specialists in biotech
- One Nucleus
- Stevenage Bioscience Catalyst
About the BioBeat19 summit
Time: 1.30-6.30 pm, Tuesday 19 November
Location: GSK Auditorium, GSK Research and Development Campus, Stevenage SG1 2NY
BioBeat19: Accelerating Cell and Gene Therapy is a half-day event for scientists, investors and entrepreneurs, discussing opportunities and catalysing ideas to deliver global health impact from the next generation of advanced biological therapies.
Emma Walmsley, CEO, GSK will deliver the keynote address, followed by leading women in the sector examining the journey from science to patients and what value means for different people and organisations.
View the full programme and register to attend at Biobeat19.org
About BioBeat
BioBeat connects entrepreneurs with leaders in biotech, by working to respond to challenges and open opportunities through the inspirational experience of women leaders. Miranda Weston-Smith founded BioBeat to bring fresh energy and insights into biotech for a healthier world.
BioBeat has produced the 50 Movers & Shakers in BioBusiness report every year since 2014, identifying outstanding female leadership talent in UK bioscience. The annual BioBeat summit brings together pioneers in biotech to nurture innovation and forge new partnerships.